RLYB news

Latest 1 stories · newest Jun 1, 2026

RLYB

Rallybio to merge with Avenzo Therapeutics in all-stock transaction

Rallybio Corporation has entered into a definitive merger agreement to combine with Avenzo Therapeutics, with Avenzo becoming a wholly-owned subsidiary. The merger represents a significant corporate restructuring for the biopharmaceutical company.

M&A Jun 1, 2026 sentiment 0.00 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same RLYB feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/RLYB/newsSTART FREE